INSTITUTE for MEDICAL SCIENCE and TECHNOLOGY
If you are an investor in early-stage biomedical device companies
… IMSaT can:
- Increase your deal flow by providing a pipeline of very well-developed venture opportunities backed by strong IP and comprehensive market research
- Help you perform clinical and technical due diligence on potential investments
- De-risk your investments by providing integrated technology or product development services to your investee companies, up to and including pre-clinical trials, and linked to the UK’s National Health Service (NHS)
- De-risk your investments by helping your investee companies leverage external (public) funding